¼¼°èÀÇ °üÀý ³» º¸Ãæ ¿ä¹ý ½ÃÀå : »ê¾÷ ºÐ¼®, ±Ô¸ð, Á¡À¯À², ¼ºÀå, µ¿Çâ ¿¹Ãø(2024-2033³â)
Viscosupplementation Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2033
»ùÇà ¿äû ¸ñ·Ï¿¡ Ãß°¡
Persistence Market Research´Â ¼¼°è °üÀý ³» º¸Ãæ Ä¡·á ½ÃÀå¿¡ ´ëÇÑ Á¾ÇÕÀûÀÎ º¸°í¼¸¦ ¹ßÇ¥Çß½À´Ï´Ù. ÀÌ º¸°í¼´Â ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ, µ¿Çâ, ±âȸ, °úÁ¦ µî ÁÖ¿ä ½ÃÀå ¿ªÇÐÀ» »ó¼¼ÇÏ°Ô Æò°¡ÇÏ°í ½ÃÀå ±¸Á¶¿¡ ´ëÇÑ ÀÚ¼¼ÇÑ ÅëÂû·ÂÀ» Á¦°øÇÕ´Ï´Ù.
ÁÖ¿ä ÀλçÀÌÆ®
°üÀý ³» º¸Ãæ ¿ä¹ý ½ÃÀå ±Ô¸ð(2024E) : 59¾ï ´Þ·¯
¿¹Ãø ½ÃÀå °¡Ä¡(2033F) : 136¾ï ´Þ·¯
¼¼°è ½ÃÀå ¼ºÀå·ü(CAGR 2024³âºÎÅÍ 2033³â±îÁö) : 9.7%
°üÀý ³» º¸Ãæ Ä¡·á ½ÃÀå - º¸°í ¹üÀ§:
°üÀý ³» º¸Ãæ¿ä¹ýÀº °üÀý¿¡ È÷¾Ë·ç·Ð»êÀ̳ª ±âŸ °üÀý³» º¸Ãæ¿ä¹ýÀ» ÁÖÀÔÇÏ¿© À±È°À» ÁÖ°í ÅëÁõÀ» ¿ÏȽÃŰ´Â °ÍÀ¸·Î, º¯Çü¼º °üÀýÁõÀÇ Ä¡·á¿¡ ÀÚÁÖ »ç¿ëµË´Ï´Ù. ÀÌ ½ÃÀå¿¡´Â ´Üȸ ÁÖ»ç¿ë°ú º¹¼öȸ ÁÖ»ç¿ë °üÀý³» º¸Ãæ¿ä¹ý µî ´Ù¾çÇÑ Á¦Ç° À¯ÇüÀÌ ÀÖÀ¸¸ç, º´¿ø, Á¤Çü¿Ü°ú Ŭ¸®´Ð, Àü¹®Ä¡·á¼¾ÅÍ¿ëÀ¸·Î °ø±ÞµÇ°í ÀÖ½À´Ï´Ù. ½ÃÀå ¼ºÀåÀÇ ¿øµ¿·ÂÀº °ñ°üÀý¿°ÀÇ À¯º´·ü Áõ°¡, ³ëÀÎ Àα¸ Áõ°¡, Ä¡·á È¿°ú ¹× ȯÀÚ °á°ú¸¦ Çâ»ó½ÃŰ´Â °üÀý ³» º¸Ãæ Ä¡·á ±â¼úÀÇ Áøº¸ÀÔ´Ï´Ù.
½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ:
¼¼°è °üÀý ³» º¸Ãæ ¿ä¹ý ½ÃÀåÀº È¿°úÀûÀÎ °ü¸® ¼Ö·ç¼ÇÀÌ ÇÊ¿äÇÑ °ñ°üÀý¿°ÀÇ ÀÌȯÀ² Áõ°¡¿Í °°Àº ¸î °¡Áö Áß¿äÇÑ ¿äÀο¡ ÀÇÇØ °ßÀεǰí ÀÖ½À´Ï´Ù. ºñ¿Ü°úÀû Ä¡·áÀÇ ¼±Åÿ¡ ´ëÇÑ ÀÇ½Ä Áõ°¡¿Í °üÀý Àå¾Ö¸¦ ÀÏÀ¸Å°±â ½¬¿î ³ëÀÎ Àα¸ Áõ°¡´Â ½ÃÀåÀÇ ¼ºÀåÀ» ´õ¿í Çâ»ó½Ã۰í ÀÖ½À´Ï´Ù. °³¼±µÈ °üÀý³» º¸Ãæ ¿ä¹ý Á¦Çü ¹× Àü´Þ ½Ã½ºÅÛÀÇ °³¹ß°ú °°Àº ±â¼úÀû Áøº¸´Â È¿´ÉÀÇ Çâ»ó°ú ȯÀÚÀÇ Æí¾ÈÇÔÀ» Á¦°øÇÕ´Ï´Ù. °Ô´Ù°¡ ´Ù¸¥ °üÀýÁúȯ¿¡¼ °üÀý³» º¸Ãæ¿ä¹ýÀÇ Àû¿ë È®´ë¿Í ÇコÄɾî ÅõÀÚ Áõ°¡°¡ ½ÃÀå È®´ë¸¦ Áö¿øÇϰí ÀÖ½À´Ï´Ù.
½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀÎ:
À¯¸ÁÇÑ ¼ºÀå ÀáÀç·Â¿¡µµ ºÒ±¸ÇÏ°í °üÀý ³» º¸Ãæ ¿ä¹ý ½ÃÀåÀº °í¾×ÀÇ Ä¡·áºñ¿Í Á¦ÇÑµÈ »óȯ ¹üÀ§¿Í °ü·ÃµÈ ¹®Á¦¿¡ Á÷¸éÇϰí ÀÖ½À´Ï´Ù. ƯÈ÷ °Ç° °ü¸® ¿¹»êÀÌ Á¦ÇÑµÈ Áö¿ª¿¡¼´Â °üÀý ³» º¸Ãæ ¿ä¹ý ÁÖ»ç¿Í °ü·ÃµÈ ºñ¿ëÀÌ Á¢±Ù À庮ÀÌ µÉ ¼ö ÀÖ½À´Ï´Ù. ¶ÇÇÑ, °üÀý ³» º¸Ãæ ¿ä¹ýÀÇ Àå±âÀûÀÎ ¾ÈÀü°ú È¿´É, ºÎÀÛ¿ë °¡´É¼º¿¡ ´ëÇÑ ¿ì·Á´Â ½ÃÀå ¼ºÀå¿¡ ¿µÇâÀ» ÁÙ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ¹®Á¦¸¦ ÇØ°áÇÏ·Á¸é ºñ¿ë È¿À²¼ºÀ» °³¼±Çϰí Á¾ÇÕÀûÀÎ ¾ÈÀü¼º Æò°¡¸¦ º¸ÀåÇϱâ À§ÇÑ ³ë·ÂÀÌ ÇÊ¿äÇÕ´Ï´Ù.
½ÃÀå ±âȸ:
°üÀý ³» º¸Ãæ ¿ä¹ý ½ÃÀåÀº ±â¼ú Áøº¸, Àα¸ ¿ªÇÐ º¯È ¹× °Ç° °ü¸® ¸ðµ¨ÀÇ ÁøÈ·Î Å« ºñÁî´Ï½º ±âȸ¸¦ Á¦°øÇÕ´Ï´Ù. °³·®Çü Á¦Á¦³ª ¼¹æÇü ½Ã½ºÅÛ µî °üÀý³» º¸Ãæ¿ä¹ýÁ¦Ç°ÀÇ Çõ½ÅÀº »õ·Î¿î ¼ºÀåÀÇ ±æÀ» ¿¾ú½À´Ï´Ù. ¶ÇÇÑ, ³·Àº ħ½À ¼ö¼úÀÇ Ã¤¿ë Áõ°¡¿Í Àç»ý ÀÇ·á Áøº¸´Â ½ÃÀå °ü°èÀÚ¿¡°Ô À¯¸ÁÇÑ Àü¸ÁÀ» Á¦°øÇÕ´Ï´Ù. Àü·«Àû Á¦ÈÞ, R&D ÅõÀÚ, ºñ¿ë È¿À²ÀûÀÎ ¼Ö·ç¼ÇÀÇ µµÀÔÀº »õ·Î¿î ±âȸ¸¦ Ȱ¿ëÇÏ°í ½ÃÀå °æÀï·ÂÀ» À¯ÁöÇÏ´Â µ¥ ¸Å¿ì Áß¿äÇÕ´Ï´Ù.
ÀÌ º¸°í¼¿¡¼ ´Ù·ç´Â ÁÖ¿ä Áú¹®
¼¼°è °üÀý ³» º¸Ãæ Ä¡·á ½ÃÀåÀÇ ¼ºÀåÀ» °¡¼ÓÇÏ´Â ÁÖ¿ä ¿äÀÎÀº ¹«¾ùÀΰ¡?
¾î¶² À¯ÇüÀÇ °üÀý ³» º¸Ãæ ¿ä¹ý Á¦Ç°ÀÌ ´Ù¾çÇÑ °Ç° °ü¸® ÇöÀå¿¡¼ Áö¿øÀ» ¹Þ°í Àִ°¡?
±â¼úÀÇ Áøº¸´Â °üÀý ³» º¸Ãæ Ä¡·á ½ÃÀå °æÀï ±¸µµ¿¡ ¾î¶² ¿µÇâÀ» ¹ÌÄ¡´Â°¡?
°üÀý ³» º¸Ãæ ¿ä¹ý ½ÃÀåÀÇ ÁÖ¿ä ±â¾÷Àº ´©±¸ÀÌ¸ç ½ÃÀåÀÇ °ü·Ã¼ºÀ» À¯ÁöÇϱâ À§ÇØ ¾î¶² Àü·«À» äÅÃÇϰí Àִ°¡?
¼¼°èÀÇ °üÀý³» º¸Ãæ ¿ä¹ý ½ÃÀåÀÇ »õ·Î¿î µ¿Çâ°ú Àå·¡¼ºÀº?
¸ñÂ÷
Á¦1Àå ÁÖ¿ä ¿ä¾à
Á¦2Àå ½ÃÀå °³¿ä
½ÃÀå ¹üÀ§/ºÐ·ù
½ÃÀåÀÇ Á¤ÀÇ/¹üÀ§/Á¦ÇÑ
Á¦3Àå ½ÃÀå ¸®½ºÅ©¿Í µ¿Çâ Æò°¡
¸®½ºÅ© Æò°¡
COVID-19 À§±â¿Í °üÀý ³» º¸Ãæ ¿ä¹ý ¼ö¿ä¿¡ ´ëÇÑ ¿µÇâ
°ú°ÅÀÇ À§±â¿Í ºñ±³ÇÑ COVID-19ÀÇ ¿µÇâ º¥Ä¡¸¶Å©
½ÃÀå ¸ÅÃâ¿¡ ¹ÌÄ¡´Â ¿µÇâ(10¾ï ´Þ·¯)
ÁÖ¿ä±¹¿¡ ÀÇÇÑ Æò°¡
ÁÖ¿ä ½ÃÀå ºÎ¹®º° Æò°¡
°ø±Þ¾÷ü¿¡ ´ëÇÑ ¾×¼Ç Æ÷ÀÎÆ® ¹× ±ÇÀå »çÇ×
½ÃÀå¿¡ ¿µÇâÀ» ÁÖ´Â ÁÖ¿ä µ¿Çâ
󹿰ú Á¦Ç° °³¹ß µ¿Çâ
Á¦4Àå ½ÃÀå ¹è°æ°ú ±âÃÊ µ¥ÀÌÅÍ Æ÷ÀÎÆ®
¼¼°èÀÇ °üÀý³» º¸Ãæ ¿ä¹ý ½ÃÀå(10¾ï ´Þ·¯)
°üÀý ³» º¸Ãæ ¿ä¹ý ½ÃÀå ±âȸ Æò°¡(10¾ï ´Þ·¯)
ÃÑ ½ÃÀå ±Ô¸ð
¼ºñ½º °¡´ÉÇÑ ÁÖ¼Ò °¡´ÉÇÑ ½ÃÀå
¼ºñ½º °¡´ÉÇÑ ÀÔ¼ö °¡´ÉÇÑ ½ÃÀå
½ÃÀå ½Ã³ª¸®¿À ¿¹Ãø
³«°üÀû ½Ã³ª¸®¿À ¼ö¿ä
¿¹»óµÇ´Â ½Ã³ª¸®¿À ¼ö¿ä
º¸¼öÀûÀÎ ½Ã³ª¸®¿À ¼ö¿ä
ÅõÀÚ ½ÇÇö °¡´É¼º ºÐ¼®
±âÁ¸ ½ÃÀå ÅõÀÚ
´Ü±âÀûÀ¸·Î´Â
Àå±âÀûÀ¸·Î´Â
½ÅÈï ½ÃÀå ÅõÀÚ
´Ü±âÀûÀ¸·Î´Â
Àå±âÀûÀ¸·Î´Â
¿¹Ãø ¿äÀÎ- °ü·Ã¼º°ú ¿µÇâ
Åé ±â¾÷ ¼ºÀå
¼¼°èÀÇ °üÀý³» º¸Ãæ ¿ä¹ý ½ÃÀåÀÇ ¼ºÀå
Áö¿ª ³Ã¹æ µµÀÔ·ü(±¹°¡º°)
½ÃÀå ¿ªÇÐ
½ÃÀå ¼ºÀå ÃËÁø¿äÀΰú ¿µÇâ Æò°¡
ÁÖ¿ä ½ÃÀåÀÇ °úÁ¦¿Í ¿µÇâ Æò°¡
°üÀý ³» º¸Ãæ ¿ä¹ý ½ÃÀå ±âȸ
¼¼°è ½ÃÀåÀÇ ÇöÀúÇÑ µ¿Çâ°ú ±× ¿µÇâ Æò°¡
Á¦5Àå Áß¿ä ¼º°ø ¿äÀÎ
Á¦Á¶¾÷ü´Â ħÅõÀ²Àº ³·Áö¸¸ ¼ºÀå·üÀÌ ³ôÀº ½ÃÀå¿¡ ÁÖ·Â
ºÎ¹®ÀÇ ³ôÀº ÁõºÐ ±âȸ¿¡ º£ÆÃ
ÇÇ¾î º¥Ä¡¸¶Å©
Á¦6Àå ¼¼°èÀÇ °üÀý³» º¸Ãæ ¿ä¹ý ½ÃÀå ¼ö¿ä ºÐ¼®
°ú°Å ½ÃÀå ºÐ¼®, 2019-2023
½ÃÀå ¿¹Ãø, 2024-2033³â
Àü³â´ëºñ ¼ºÀå µ¿Ç⠺м®
Á¦7Àå ¼¼°èÀÇ °üÀý³» º¸Ãæ ¿ä¹ý ½ÃÀå ¸ÅÃ⠺м®
½ÃÀå ¸ÅÃâ(10¾ï ´Þ·¯) ºÐ¼®, 2019-2023³â
½ÃÀå ¸ÅÃâ(10¾ï ´Þ·¯) ¿¹Ãø, 2024-2033³â
Àü³â´ëºñ ¼ºÀå µ¿Ç⠺м®
Àý´ë ¼öÀÍ ±âȸ
Á¦8Àå ¼¼°èÀÇ °üÀý³» º¸Ãæ¿ä¹ý ½ÃÀå ºÐ¼® : Á¦Ç° À¯Çüº°
¼Ò°³/ÁÖ¿ä Á¶»ç °á°ú
½ÃÀå ±Ô¸ð(10¾ï ´Þ·¯) ºÐ¼®, 2019-2023³â
½ÃÀå ±Ô¸ð(10¾ï ´Þ·¯) ºÐ¼®°ú ¿¹Ãø, 2024-2033³â
1ȸ ÁÖ»ç
3ȸ ÁÖ»ç
5ȸ ÁÖ»ç
Á¦Ç° À¯Çüº° ½ÃÀåÀÇ ¸Å·Â ºÐ¼®
Á¦9Àå ¼¼°èÀÇ °üÀý³» º¸Ãæ¿ä¹ý ½ÃÀå ºÐ¼® : ÃÖÁ¾ »ç¿ëÀÚº°
¼Ò°³/ÁÖ¿ä Á¶»ç °á°ú
½ÃÀå ±Ô¸ð(10¾ï ´Þ·¯) ºÐ¼®, 2019-2023³â
½ÃÀå ±Ô¸ð(10¾ï ´Þ·¯) ºÐ¼®°ú ¿¹Ãø, 2024-2033³â
º´¿ø
Á¤Çü¿Ü°ú Ŭ¸®´Ð/¿Ü·¡¼ö¼ú¼¾ÅÍ(ASC)
ÃÖÁ¾ »ç¿ëÀÚº° ½ÃÀåÀÇ ¸Å·Â ºÐ¼®
Á¦10Àå ¼¼°èÀÇ °üÀý³» º¸Ãæ¿ä¹ý ½ÃÀå ºÐ¼® : Áö¿ªº°
¼Ò°³
½ÃÀå ±Ô¸ð(10¾ï ´Þ·¯) ºÐ¼®, 2019-2023³â
½ÃÀå ±Ô¸ð(10¾ï ´Þ·¯) ºÐ¼®°ú ¿¹Ãø, 2024-2033³â
ºÏ¹Ì
¶óƾ¾Æ¸Þ¸®Ä«
À¯·´
¾Æ½Ã¾ÆÅÂÆò¾ç
Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
Áö¿ªº° ½ÃÀåÀÇ ¸Å·Â ºÐ¼®
Á¦11Àå ºÏ¹Ì °üÀý³» º¸Ãæ¿ä¹ý ½ÃÀå ºÐ¼®
Á¦12Àå ¶óÆ¾¾Æ¸Þ¸®Ä«ÀÇ °üÀý ³» º¸Ãæ ¿ä¹ý ½ÃÀå ºÐ¼®
Á¦13Àå À¯·´ °üÀý ³» º¸Ãæ ¿ä¹ý ½ÃÀå ºÐ¼®
Á¦14Àå ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ °üÀý ³» º¸Ãæ ¿ä¹ý ½ÃÀå ºÐ¼®
Á¦15Àå Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«ÀÇ °üÀý ³» º¸Ãæ ¿ä¹ý ½ÃÀå ºÐ¼®
Á¦16Àå ÁÖ¿ä±¹ÀÇ °üÀý³» º¸Ãæ¿ä¹ý ½ÃÀå ºÐ¼®
¼Ò°³
ÁÖ¿ä ±¹°¡º° ½ÃÀå ¸ÅÃâ ºñÀ² ºÐ¼®
¼¼°è¿Í ±¹°¡º° ¼ºÀå ºñ±³
¹Ì±¹ÀÇ °üÀý³» º¸Ãæ ¿ä¹ý ½ÃÀå ºÐ¼®
½ÃÀå ºÐ·ùº° °¡Ä¡ ºñÀ² ºÐ¼®
½ÃÀå ºÐ·ùº° °¡Ä¡¿Í ºÐ¼® ¹× ¿¹Ãø, 2019-2032³â
ij³ª´Ù °üÀý ³» º¸Ãæ ¿ä¹ý ½ÃÀå ºÐ¼®
½ÃÀå ºÐ·ùº° °¡Ä¡ ºñÀ² ºÐ¼®
½ÃÀå ºÐ·ùº° °¡Ä¡¿Í ºÐ¼® ¹× ¿¹Ãø, 2019-2032³â
¸ß½ÃÄÚ °üÀý ³» º¸Ãæ ¿ä¹ý ½ÃÀå ºÐ¼®
½ÃÀå ºÐ·ùº° °¡Ä¡ ºñÀ² ºÐ¼®
½ÃÀå ºÐ·ùº° °¡Ä¡¿Í ºÐ¼® ¹× ¿¹Ãø, 2019-2032³â
ºê¶óÁú °üÀý ³» º¸Ãæ ¿ä¹ý ½ÃÀå ºÐ¼®
½ÃÀå ºÐ·ùº° °¡Ä¡ ºñÀ² ºÐ¼®
½ÃÀå ºÐ·ùº° °¡Ä¡¿Í ºÐ¼® ¹× ¿¹Ãø, 2019-2032³â
µ¶ÀÏ °üÀý ³» º¸Ãæ ¿ä¹ý ½ÃÀå ºÐ¼®
½ÃÀå ºÐ·ùº° °¡Ä¡ ºñÀ² ºÐ¼®
½ÃÀå ºÐ·ùº° °¡Ä¡¿Í ºÐ¼® ¹× ¿¹Ãø, 2019-2032³â
ÇÁ¶û½º °üÀý ³» º¸Ãæ ¿ä¹ý ½ÃÀå ºÐ¼®
½ÃÀå ºÐ·ùº° °¡Ä¡ ºñÀ² ºÐ¼®
½ÃÀå ºÐ·ùº° °¡Ä¡¿Í ºÐ¼® ¹× ¿¹Ãø, 2019-2032³â
ÀÌÅ»¸®¾ÆÀÇ °üÀý³» º¸Ãæ ¿ä¹ý ½ÃÀå ºÐ¼®
½ÃÀå ºÐ·ùº° °¡Ä¡ ºñÀ² ºÐ¼®
½ÃÀå ºÐ·ùº° °¡Ä¡¿Í ºÐ¼® ¹× ¿¹Ãø, 2019-2032³â
º£³×·è½º °üÀý ³» º¸Ãæ ¿ä¹ý ½ÃÀå ºÐ¼®
½ÃÀå ºÐ·ùº° °¡Ä¡ ºñÀ² ºÐ¼®
½ÃÀå ºÐ·ùº° °¡Ä¡¿Í ºÐ¼® ¹× ¿¹Ãø, 2019-2032³â
¿µ±¹ °üÀý ³» º¸Ãæ ¿ä¹ý ½ÃÀå ºÐ¼®
½ÃÀå ºÐ·ùº° °¡Ä¡ ºñÀ² ºÐ¼®
½ÃÀå ºÐ·ùº° °¡Ä¡¿Í ºÐ¼® ¹× ¿¹Ãø, 2019-2032³â
ºÏÀ¯·´ ±¹°¡ÀÇ °üÀý ³» º¸Ãæ ¿ä¹ý ½ÃÀå ºÐ¼®
½ÃÀå ºÐ·ùº° °¡Ä¡ ºñÀ² ºÐ¼®
½ÃÀå ºÐ·ùº° °¡Ä¡¿Í ºÐ¼® ¹× ¿¹Ãø, 2019-2032³â
Áß±¹ °üÀý ³» º¸Ãæ ¿ä¹ý ½ÃÀå ºÐ¼®
½ÃÀå ºÐ·ùº° °¡Ä¡ ºñÀ² ºÐ¼®
½ÃÀå ºÐ·ùº° °¡Ä¡¿Í ºÐ¼® ¹× ¿¹Ãø, 2019-2032³â
ÀϺ»ÀÇ °üÀý ³» º¸Ãæ ¿ä¹ý ½ÃÀå ºÐ¼®
½ÃÀå ºÐ·ùº° °¡Ä¡ ºñÀ² ºÐ¼®
½ÃÀå ºÐ·ùº° °¡Ä¡¿Í ºÐ¼® ¹× ¿¹Ãø, 2019-2032³â
Çѱ¹ÀÇ °üÀý³» º¸Ãæ ¿ä¹ý ½ÃÀå ºÐ¼®
½ÃÀå ºÐ·ùº° °¡Ä¡ ºñÀ² ºÐ¼®
½ÃÀå ºÐ·ùº° °¡Ä¡¿Í ºÐ¼® ¹× ¿¹Ãø, 2019-2032³â
GCC ±¹°¡ÀÇ °üÀý ³» º¸Ãæ ¿ä¹ý ½ÃÀå ºÐ¼®
½ÃÀå ºÐ·ùº° °¡Ä¡ ºñÀ² ºÐ¼®
½ÃÀå ºÐ·ùº° °¡Ä¡¿Í ºÐ¼® ¹× ¿¹Ãø, 2019-2032³â
³²¾ÆÇÁ¸®Ä«ÀÇ °üÀý ³» º¸Ãæ ¿ä¹ý ½ÃÀå ºÐ¼®
½ÃÀå ºÐ·ùº° °¡Ä¡ ºñÀ² ºÐ¼®
½ÃÀå ºÐ·ùº° °¡Ä¡¿Í ºÐ¼® ¹× ¿¹Ãø, 2019-2032³â
ÅÍŰ °üÀý ³» º¸Ãæ ¿ä¹ý ½ÃÀå ºÐ¼®
½ÃÀå ºÐ·ùº° °¡Ä¡ ºñÀ² ºÐ¼®
½ÃÀå ºÐ·ùº° °¡Ä¡¿Í ºÐ¼® ¹× ¿¹Ãø, 2019-2032³â
±¹³» °æÀï ±¸µµ¿Í ±â¾÷ÀÇ ÁýÁßµµ
Á¦17Àå ½ÃÀå ±¸Á¶ ºÐ¼®
±â¾÷ Tierº° ½ÃÀå ºÐ¼®
½ÃÀå ÁýÁß
ÁÖ¿ä ±â¾÷ÀÇ ½ÃÀå Á¡À¯À² ºÐ¼®
½ÃÀåÇöÀçºÐ¼®
Á¦18Àå °æÀï ºÐ¼®
°æÀï ´ë½Ãº¸µå
°æÀï º¥Ä¡¸¶Å·
°æÀïÀÇ »ó¼¼
Sanofi
Anika Therapeutics, Inc.
SEIKAGAKU CORPORATION
Zimmer Biomet
Smith &Nephew PLC
Ferring Pharmaceutical BV
Lifecore Biomedical, LLC(Landec)
LG Life Sciences Ltd.
Fidia Farmaceutici SpA
F.Hoffmann-La Roche Ltd.
Á¦19Àå »ç¿ëµÈ ÀüÁ¦Á¶°Ç°ú ¾à¾î
Á¦20Àå Á¶»ç ¹æ¹ý
JHS
Persistence Market Research has recently released a comprehensive report on the global visco-supplementation market. This report provides an in-depth evaluation of key market dynamics, including drivers, trends, opportunities, and challenges, delivering detailed insights into the market structure.
Key Insights:
Visco-supplementation Market Size (2024E): USD 5.9 Billion
Projected Market Value (2033F): USD 13.6 Billion
Global Market Growth Rate (CAGR 2024 to 2033): 9.7%
Visco-supplementation Market - Report Scope:
Visco-supplementation involves the injection of hyaluronic acid or other viscosupplements into the joints to provide lubrication and relieve pain, commonly used in the treatment of osteoarthritis. The market includes various product types, such as single-injection and multi-injection viscosupplements, and caters to hospitals, orthopedic clinics, and specialized treatment centers. Market growth is driven by the increasing prevalence of osteoarthritis, rising geriatric population, and advancements in viscosupplement technology, enhancing treatment efficacy and patient outcomes.
Market Growth Drivers:
The global visco-supplementation market is driven by several key factors, including the growing incidence of osteoarthritis, which necessitates effective management solutions. The increasing awareness of non-surgical treatment options, coupled with the rising geriatric population prone to joint disorders, further propels market growth. Technological advancements, such as the development of improved viscosupplement formulations and delivery systems, offer enhanced efficacy and patient comfort. Additionally, the expanding application of viscosupplementation in other joint disorders and rising healthcare investments support market expansion.
Market Restraints:
Despite its promising growth potential, the visco-supplementation market faces challenges related to high treatment costs and limited reimbursement coverage. The expense associated with viscosupplement injections can be a barrier to access, particularly in regions with constrained healthcare budgets. Furthermore, concerns regarding the long-term safety and effectiveness of viscosupplementation treatments and the potential for adverse reactions may impact market growth. Addressing these issues requires efforts to improve cost-effectiveness and ensure comprehensive safety assessments.
Market Opportunities:
The visco-supplementation market presents significant opportunities driven by technological advancements, demographic shifts, and evolving healthcare models. Innovations in viscosupplement products, such as enhanced formulations and extended-release systems, create new growth avenues. Additionally, the increasing adoption of minimally invasive procedures and advancements in regenerative medicine offer promising prospects for market players. Strategic collaborations, investment in research and development, and the introduction of cost-effective solutions are crucial to capitalizing on emerging opportunities and maintaining market competitiveness.
Key Questions Answered in the Report:
What are the primary factors driving the growth of the visco-supplementation market globally?
Which types of viscosupplement products are gaining traction across various healthcare settings?
How are technological advancements influencing the competitive landscape of the visco-supplementation market?
Who are the key players in the visco-supplementation market, and what strategies are they employing to sustain market relevance?
What are the emerging trends and future prospects in the global visco-supplementation market?
Competitive Intelligence and Business Strategy:
Leading players in the global visco-supplementation market, including Allergan, Anika Therapeutics, and Seikagaku Corporation, focus on innovation, product differentiation, and strategic partnerships to secure a competitive edge. These companies invest in R&D to develop advanced viscosupplement products, such as novel hyaluronic acid formulations and enhanced delivery systems. Collaborations with healthcare providers and distributors facilitate market access and promote technology adoption. Additionally, emphasis on clinical research, evidence-based practice, and patient education supports market growth and improves treatment outcomes in the evolving visco-supplementation landscape.
Key Companies Profiled:
Allergan
Anika Therapeutics
Seikagaku Corporation
Revive Therapeutics
Mylan N.V.
Ferring Pharmaceuticals
BioRestorative Therapies
OrthogenRx Inc.
Celgene Corporation
Merz Pharmaceuticals
Market Segments Covered in Viscosupplementation Market Industry Analysis
By Product Type
Single Injection
Three Injection
Five Injection
By End User
Hospitals
Orthopaedic Clinics/Ambulatory Surgical Centres (ASCs)
Table of Contents
1. Executive Summary
1.1. Global Market Outlook
1.2. Summary of Statistics
1.3. Key Market Characteristics & Attributes
1.4. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
3. Market Risks and Trends Assessment
3.1. Risk Assessment
3.1.1. COVID-19 Crisis and Impact on Viscosupplementation Demand
3.1.2. COVID-19 Impact Benchmark with Previous Crisis
3.1.3. Impact on Market Value (US$ Bn)
3.1.4. Assessment by Key Countries
3.1.5. Assessment by Key Market Segments
3.1.6. Action Points and Recommendation for Suppliers
3.2. Key Trends Impacting the Market
3.3. Formulation and Product Development Trends
4. Market Background and Foundation Data Points
4.1. Global Viscosupplementation Market (US$ Bn)
4.2. Viscosupplementation Market Opportunity Assessment (US$ Bn)
4.2.1. Total Available Market
4.2.2. Serviceable Addressable Market
4.2.3. Serviceable Obtainable Market
4.3. Market Scenario Forecast
4.3.1. Demand in optimistic Scenario
4.3.2. Demand in Likely Scenario
4.3.3. Demand in Conservative Scenario
4.4. Investment Feasibility Analysis
4.4.1. Investment in Established Markets
4.4.1.1. In Short Term
4.4.1.2. In Long Term
4.4.2. Investment in Emerging Markets
4.4.2.1. In Short Term
4.4.2.2. In Long Term
4.5. Forecast Factors - Relevance & Impact
4.5.1. Top Companies Historical Growth
4.5.2. Global Viscosupplementation Market Growth
4.5.3. District Cooling Adoption Rate, By Country
4.6. Market Dynamics
4.6.1. Market Driving Factors and Impact Assessment
4.6.2. Prominent Market Challenges and Impact Assessment
4.6.3. Viscosupplementation Market Opportunities
4.6.4. Prominent Trends in the Global Market & Their Impact Assessment
5. Key Success Factors
5.1. Manufacturers' Focus on Low Penetration High Growth Markets
5.2. Banking on with Segments High Incremental Opportunity
5.3. Peer Benchmarking
6. Global Viscosupplementation Market Demand Analysis 2019-2023 and Forecast, 2024-2033
6.1. Historical Market Analysis, 2019-2023
6.2. Current and Future Market Projections, 2024-2033
6.3. Y-o-Y Growth Trend Analysis
7. Global Viscosupplementation Market Value Analysis 2019-2023 and Forecast, 2024-2033
7.1. Historical Market Value (US$ Bn) Analysis, 2019-2023
7.2. Current and Future Market Value (US$ Bn) Projections, 2024-2033
7.2.1. Y-o-Y Growth Trend Analysis
7.2.2. Absolute $ Opportunity Analysis
8. Global Viscosupplementation Market Analysis 2019-2023 and Forecast 2024-2033, By Product Type
8.1. Introduction / Key Findings
8.2. Historical Market Size (US$ Bn) Analysis By Product Type, 2019-2023
8.3. Current and Future Market Size (US$ Bn) Analysis and Forecast By Product Type, 2024-2033
8.3.1. Single Injection
8.3.2. Three Injection
8.3.3. Five Injection
8.4. Market Attractiveness Analysis By Product Type
9. Global Viscosupplementation Market Analysis 2019-2023 and Forecast 2024-2033, By End User
9.1. Introduction / Key Findings
9.2. Historical Market Size (US$ Bn) Analysis By End User, 2019-2023
9.3. Current and Future Market Size (US$ Bn) Analysis and Forecast By End User, 2024-2033
9.3.1. Hospitals
9.3.2. Orthopedic Clinics/Ambulatory Surgical Centers (ASCs)
9.4. Market Attractiveness Analysis By End User
10. Global Viscosupplementation Market Analysis 2019-2023 and Forecast 2024-2033, By Region
10.1. Introduction
10.2. Historical Market Size (US$ Bn) Analysis By Region, 2019-2023
10.3. Current Market Size (US$ Bn) & Analysis and Forecast By Region, 2024-2033
10.3.1. North America
10.3.2. Latin America
10.3.3. Europe
10.3.4. Asia Pacific
10.3.5. Middle East and Africa (MEA)
10.4. Market Attractiveness Analysis By Region
11. North America Viscosupplementation Market Analysis 2019-2023 and Forecast 2024-2033
11.1. Introduction
11.2. Pricing Analysis
11.3. Historical Market Value (US$ Bn) Trend Analysis By Market Taxonomy, 2019-2023
11.4. Market Value (US$ Bn) & Forecast By Market Taxonomy, 2024-2033
11.4.1. By Country
11.4.1.1. U.S.
11.4.1.2. Canada
11.4.1.3. Rest of North America
11.4.2. By Product Type
11.4.3. By End User
11.5. Market Attractiveness Analysis
11.5.1. By Country
11.5.2. By Product Type
11.5.3. By End User
12. Latin America Viscosupplementation Market Analysis 2019-2023 and Forecast 2024-2033
12.1. Introduction
12.2. Pricing Analysis
12.3. Historical Market Value (US$ Bn) Trend Analysis By Market Taxonomy, 2019-2023
12.4. Market Value (US$ Bn) & Forecast By Market Taxonomy, 2024-2033
12.4.1. By Country
12.4.1.1. Brazil
12.4.1.2. Mexico
12.4.1.3. Rest of Latin America
12.4.2. By Product Type
12.4.3. By End User
12.5. Market Attractiveness Analysis
12.5.1. By Country
12.5.2. By Product Type
12.5.3. By End User
13. Europe Viscosupplementation Market Analysis 2019-2023 and Forecast 2024-2033
13.1. Introduction
13.2. Pricing Analysis
13.3. Historical Market Value (US$ Bn) Trend Analysis By Market Taxonomy, 2019-2023
13.4. Market Value (US$ Bn) & Forecast By Market Taxonomy, 2024-2033
13.4.1. By Country
13.4.1.1. Germany
13.4.1.2. France
13.4.1.3. U.K.
13.4.1.4. Italy
13.4.1.5. Benelux
13.4.1.6. Nordic Countries
13.4.1.7. Rest of Europe
13.4.2. By Product Type
13.4.3. By End User
13.5. Market Attractiveness Analysis
13.5.1. By Country
13.5.2. By Product Type
13.5.3. By End User
14. Asia Pacific Viscosupplementation Market Analysis 2019-2023 and Forecast 2024-2033
14.1. Introduction
14.2. Pricing Analysis
14.3. Historical Market Value (US$ Bn) Trend Analysis By Market Taxonomy, 2019-2023
14.4. Market Value (US$ Bn) & Forecast By Market Taxonomy, 2024-2033
14.4.1. By Country
14.4.1.1. China
14.4.1.2. Japan
14.4.1.3. South Korea
14.4.1.4. Rest of Asia Pacific
14.4.2. By Product Type
14.4.3. By End User
14.5. Market Attractiveness Analysis
14.5.1. By Country
14.5.2. By Product Type
14.5.3. By End User
15. Middle East and Africa Viscosupplementation Market Analysis 2019-2023 and Forecast 2024-2033
15.1. Introduction
15.2. Pricing Analysis
15.3. Historical Market Value (US$ Bn) Trend Analysis By Market Taxonomy, 2019-2023
15.4. Market Value (US$ Bn) & Forecast By Market Taxonomy, 2024-2033
15.4.1. By Country
15.4.1.1. GCC Countries
15.4.1.2. South Africa
15.4.1.3. Turkey
15.4.1.4. Rest of Middle East and Africa
15.4.2. By Product Type
15.4.3. By End User
15.5. Market Attractiveness Analysis
15.5.1. By Country
15.5.2. By Product Type
15.5.3. By End User
16. Key Countries Viscosupplementation Market Analysis 2019-2023 and Forecast 2024-2033
16.1. Introduction
16.1.1. Market Value Proportion Analysis, By Key Countries
16.1.2. Global Vs. Country Growth Comparison
16.2. US Viscosupplementation Market Analysis
16.2.1. Value Proportion Analysis by Market Taxonomy
16.2.2. Value & Analysis and Forecast by Market Taxonomy, 2019-2032
16.2.2.1. By Product Type
16.2.2.2. By End User
16.3. Canada Viscosupplementation Market Analysis
16.3.1. Value Proportion Analysis by Market Taxonomy
16.3.2. Value & Analysis and Forecast by Market Taxonomy, 2019-2032
16.3.2.1. By Product Type
16.3.2.2. By End User
16.4. Mexico Viscosupplementation Market Analysis
16.4.1. Value Proportion Analysis by Market Taxonomy
16.4.2. Value & Analysis and Forecast by Market Taxonomy, 2019-2032
16.4.2.1. By Product Type
16.4.2.2. By End User
16.5. Brazil Viscosupplementation Market Analysis
16.5.1. Value Proportion Analysis by Market Taxonomy
16.5.2. Value & Analysis and Forecast by Market Taxonomy, 2019-2032
16.5.2.1. By Product Type
16.5.2.2. By End User
16.6. Germany Viscosupplementation Market Analysis
16.6.1. Value Proportion Analysis by Market Taxonomy
16.6.2. Value & Analysis and Forecast by Market Taxonomy, 2019-2032
16.6.2.1. By Product Type
16.6.2.2. By End User
16.7. France Viscosupplementation Market Analysis
16.7.1. Value Proportion Analysis by Market Taxonomy
16.7.2. Value & Analysis and Forecast by Market Taxonomy, 2019-2032
16.7.2.1. By Product Type
16.7.2.2. By End User
16.8. Italy Viscosupplementation Market Analysis
16.8.1. Value Proportion Analysis by Market Taxonomy
16.8.2. Value & Analysis and Forecast by Market Taxonomy, 2019-2032
16.8.2.1. By Product Type
16.8.2.2. By End User
16.9. BENELUX Viscosupplementation Market Analysis
16.9.1. Value Proportion Analysis by Market Taxonomy
16.9.2. Value & Analysis and Forecast by Market Taxonomy, 2019-2032
16.9.2.1. By Product Type
16.9.2.2. By End User
16.10. UK Viscosupplementation Market Analysis
16.10.1. Value Proportion Analysis by Market Taxonomy
16.10.2. Value & Analysis and Forecast by Market Taxonomy, 2019-2032
16.10.2.1. By Product Type
16.10.2.2. By End User
16.11. Nordic Countries Viscosupplementation Market Analysis
16.11.1. Value Proportion Analysis by Market Taxonomy
16.11.2. Value & Analysis and Forecast by Market Taxonomy, 2019-2032
16.11.2.1. By Product Type
16.11.2.2. By End User
16.12. China Viscosupplementation Market Analysis
16.12.1. Value Proportion Analysis by Market Taxonomy
16.12.2. Value & Analysis and Forecast by Market Taxonomy, 2019-2032
16.12.2.1. By Product Type
16.12.2.2. By End User
16.13. Japan Viscosupplementation Market Analysis
16.13.1. Value Proportion Analysis by Market Taxonomy
16.13.2. Value & Analysis and Forecast by Market Taxonomy, 2019-2032
16.13.2.1. By Product Type
16.13.2.2. By End User
16.14. South Korea Viscosupplementation Market Analysis
16.14.1. Value Proportion Analysis by Market Taxonomy
16.14.2. Value & Analysis and Forecast by Market Taxonomy, 2019-2032
16.14.2.1. By Product Type
16.14.2.2. By End User
16.15. GCC Countries Viscosupplementation Market Analysis
16.15.1. Value Proportion Analysis by Market Taxonomy
16.15.2. Value & Analysis and Forecast by Market Taxonomy, 2019-2032
16.15.2.1. By Product Type
16.15.2.2. By End User
16.16. South Africa Viscosupplementation Market Analysis
16.16.1. Value Proportion Analysis by Market Taxonomy
16.16.2. Value & Analysis and Forecast by Market Taxonomy, 2019-2032
16.16.2.1. By Product Type
16.16.2.2. By End User
16.17. Turkey Viscosupplementation Market Analysis
16.17.1. Value Proportion Analysis by Market Taxonomy
16.17.2. Value & Analysis and Forecast by Market Taxonomy, 2019-2032
16.17.2.1. By Product Type
16.17.2.2. By End User
16.17.3. Competition Landscape and Player Concentration in the Country
17. Market Structure Analysis
17.1. Market Analysis by Tier of Companies
17.2. Market Concentration
17.3. Market Share Analysis of Top Players
17.4. Market Presence Analysis
17.4.1. By Regional footprint of Players
17.4.2. Product footprint by Players
18. Competition Analysis
18.1. Competition Dashboard
18.2. Competition Benchmarking
18.3. Competition Deep Dive
18.3.1. Sanofi
18.3.1.1. Overview
18.3.1.2. Product Portfolio
18.3.1.3. Sales Footprint
18.3.1.4. Strategy Overview
18.3.2. Anika Therapeutics, Inc.
18.3.2.1. Overview
18.3.2.2. Product Portfolio
18.3.2.3. Sales Footprint
18.3.2.4. Strategy Overview
18.3.3. SEIKAGAKU CORPORATION
18.3.3.1. Overview
18.3.3.2. Product Portfolio
18.3.3.3. Sales Footprint
18.3.3.4. Strategy Overview
18.3.4. Zimmer Biomet
18.3.4.1. Overview
18.3.4.2. Product Portfolio
18.3.4.3. Sales Footprint
18.3.4.4. Strategy Overview
18.3.5. Smith & Nephew PLC
18.3.5.1. Overview
18.3.5.2. Product Portfolio
18.3.5.3. Sales Footprint
18.3.5.4. Strategy Overview
18.3.6. Ferring Pharmaceutical B.V.
18.3.6.1. Overview
18.3.6.2. Product Portfolio
18.3.6.3. Sales Footprint
18.3.6.4. Strategy Overview
18.3.7. Lifecore Biomedical, LLC (Landec)
18.3.7.1. Overview
18.3.7.2. Product Portfolio
18.3.7.3. Sales Footprint
18.3.7.4. Strategy Overview
18.3.8. LG Life Sciences Ltd.
18.3.8.1. Overview
18.3.8.2. Product Portfolio
18.3.8.3. Sales Footprint
18.3.8.4. Strategy Overview
18.3.9. Fidia Farmaceutici S.p.A
18.3.9.1. Overview
18.3.9.2. Product Portfolio
18.3.9.3. Sales Footprint
18.3.9.4. Strategy Overview
18.3.10. F.Hoffmann-La Roche Ltd.
18.3.10.1. Overview
18.3.10.2. Product Portfolio
18.3.10.3. Sales Footprint
18.3.10.4. Strategy Overview
19. Assumptions and Acronyms Used
20. Research Methodology